Advertisement

Regulation of Foamy Virus Gene Expression

  • A. Rethwilm
Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 193)

Abstract

Foamy viruses make up the third subgroup of the family of exogenous retroviruses (Teich 1984). They are far less well characterized than the onco- and lentiviruses.

Keywords

Human Immunodeficiency Virus Type Chronic Fatigue Syndrome Foamy Virus Simian Foamy Virus Infectious Molecular Clone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achong BG, Epstein MA (1978) Preliminary seroepidemiological studies on the human syncytial virus. J Gen Virol 40: 175–181PubMedGoogle Scholar
  2. Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 46: 299–307PubMedGoogle Scholar
  3. Aguzzi A (1993) The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta 1155: 1–24PubMedGoogle Scholar
  4. Aguzzi A, Bothe K, Wagner EF, Rethwilm A, Horak I (1992a) Human foamy virus: an underestimated neuropathogen? Brain Pathol 2: 61–69PubMedGoogle Scholar
  5. Aguzzi A, Bothe K, Anhauser I, Horak I, Rethwilm A, Wagner EF (1992b) Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol 4: 1–13Google Scholar
  6. Aguzzi A, Wagner EF, Netzer K-O, Bothe K, Anhauser I, Rethwilm A (1993) Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am J Pathol 142: 1061–1072PubMedGoogle Scholar
  7. Alford RL, Honda S, Lawrence CB, Belmont JW (1991) RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology 183: 611–619PubMedGoogle Scholar
  8. Aronoff R, Hajjar AM, Linial ML (1993) Avian retroviral RNA encapsidation: reexamination of functional 5′ RNA sequences and the role of nucleocapsid cys-his motifs. J Virol 67: 178–188PubMedGoogle Scholar
  9. Bartholomä A, Muranyi W, Flügel RM (1992) Bacterial expression of the capsid antigen domain and identification of native gag proteins in spumavirus-infected cells. Virus Res 23: 27–38PubMedGoogle Scholar
  10. Baunach G, Maurer B, Hahn H, Kranz M, Rethwilm A (1993) Functional analysis of human foamy virus accessory reading frames. J Virol 67: 5411–5418PubMedGoogle Scholar
  11. Benzair A-B, Rhodes-Feuillette A, Emanoil-Ravicovitch R, Peries J (1982) Reverse transcriptase from simian foamy virus serotype 1: purification and characterization. J Virol 44: 720–724PubMedGoogle Scholar
  12. Benzair A-B, Rhodes-Feuillette A, Lasneret J, Emanoil-Ravier R, Peries J (1985) Purification and characterization of the major envelope glycoprotein of simian foamy virus type 1. J Gen Virol 66: 1449–1455PubMedGoogle Scholar
  13. Benzair A-B, Rhodes-Feuillette A, Lasneret J, Emanoil-Ravier R, Peries J (1986) Purification and characterization of simian foamy virus type I structural core polypeptides. Arch Virol 87: 87–96PubMedGoogle Scholar
  14. Berger SL, Pina B, Silverman N, Marcus GA, Agapite J, Regier JL, Triezenberg SJ, Guarante L (1992) Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell 70: 251-265PubMedGoogle Scholar
  15. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO (1995) A comparative study of higher primate foamy viruses, including a new virus from a Gorilla. Virology (in press)Google Scholar
  16. Blair WS, Bogerd H, Cullen BR (1994) Genetic analysis indicates that the human foamy virus bel-1 protein contains a transcription activation domain of the acidic class. J Virol 68: 3803-3808PubMedGoogle Scholar
  17. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253: 555–557PubMedGoogle Scholar
  18. Bourgault I, Venet A, Levy JP (1992) Three epitopic peptides of the simian imunodeficiency virus nef protein recognized by macaque cytolytic T lymphocytes. J Virol 66: 750–756PubMedGoogle Scholar
  19. Brown P, Nemo G, Gajdusek DC (1978) Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy virus. J Infect Dis 137: 412–427Google Scholar
  20. Cameron KR, Birchall SM, Moses MA (1978) Isolation of a foamy virus from patient with dialysis encephalopathy. Lancet 2: 796PubMedGoogle Scholar
  21. Campbell M, Renshaw-Gegg L, Renne R, Luciw PA (1994) Characterization of the internal promoter of simian foamy viruses. J Virol 68: 4811–4820PubMedGoogle Scholar
  22. Chang L-J, Pryciak P, Ganem D, Varmus HE (1989) Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translation initiation not ribosomal frameshifting. Nature 337: 364–368PubMedGoogle Scholar
  23. Chang J, Lee KJ, Jang KL, Lee EK, Baek GH, Sung YC (1995) Human foamy virus bel1 transactivator contains a bibartite nuclear localization determinant which is sensitive to protein context and tripple multimerization domains. J Virol 69: 801–808PubMedGoogle Scholar
  24. Chameau P, Clavel F (1991) A single stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol 65: 2415–2421Google Scholar
  25. Cress WD, Triezenberg SJ (1991) Critical structural elements of the VP 16 transcriptional activation domain. Science 251: 87–90PubMedGoogle Scholar
  26. Cullen BR (1991a) Human Immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056PubMedGoogle Scholar
  27. Cullen BR (1991b) Regulation of human immunodeficiency virus replication. Ann Rev Microbiol 45: 219–250Google Scholar
  28. Debons-Guillemin MC, Valla J, Gazeau J, Wybier-Franqui J, Giron ML, Toubert ME, Canivet M, Peries J (1992) No evidence of spumaretrovirus infection markers in 19 cases of de Quervain’s thyroiditis. AIDS Res Hum Retrovir 8: 1547PubMedGoogle Scholar
  29. Doolittle RF, Feng DF, McClure MA, Johnson MS (1990) Retrovirus phylogeny and evolution. In: Swanstrom R, Vogt PK (eds) Retroviruses-strategies of replication. Springer, Berlin Heidelberg New York, pp 1–18 (Current topics in microbiology and immunology, vol 157)Google Scholar
  30. Enders J, Peebles T (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Biol Med 86: 277–287Google Scholar
  31. Erlwein O, Rethwilm A (1993) Bel-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 196: 256–268PubMedGoogle Scholar
  32. Flügel RM, Rethwilm A, Maurer B, Darai G (1987) Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J 6: 2077–2084PubMedGoogle Scholar
  33. Flügel RM (1991) Spumaviruses: a group of complex retroviruses. J Acquir Immune Defic Syndr 4: 739–750PubMedGoogle Scholar
  34. Flügel RM (1993) The molecular biology of the human spumavirus. In: Cullen BR (ed) Human retroviruses-frontiers in molecular biology, Oxford University Press, Oxford, pp 193–214Google Scholar
  35. Flügel RM, Rethwilm A, Maurer B, Darai G (1990) Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. Corrigenda. EMBO J 9: 3806Google Scholar
  36. Flügel RM, Mahnke C, Geiger A, Komaroff AL (1992) Absence of antibody to human spumaretrovirus in patients with chronic fatigue syndrome. Clin Infect Dis 14: 623–624PubMedGoogle Scholar
  37. Garrett ED, He F, Bogerd HP, Cullen BR (1993) Transcriptional trans activators of human and simian foamy viruses contain a small, highly conserved activation domain. J Virol 67: 6824–6827PubMedGoogle Scholar
  38. Giron M-L, Rozain F, Debons-Guillemin M-C, Cavinet M, Peries J, Emanoil-Ravier R (1993) Human foamy virus polypeptides: identification of env and bel gene products. J Virol 67: 3596–3600PubMedGoogle Scholar
  39. Gow JW, Simpson K, Schliephake A, Behan WMH, Morrison LJA, Cavanagh H, Rethwilm A, Behan PO (1992) Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol 45: 1058–1061PubMedGoogle Scholar
  40. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure MO, Rethwilm A (1994) Reactivity of primate sera to foamy virus gag and bet proteins. J Gen Virol 75: 2635–2644PubMedGoogle Scholar
  41. Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC (1989) Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 86: 9549–9553PubMedGoogle Scholar
  42. Harris JD, Scott JV, Traynor B, Brahic M, Stowring L, Ventura P, Haase AT, Peluso R (1981) Visna virus DNA: discovery of a novel gapped structure. Virology 113: 573–583PubMedGoogle Scholar
  43. Harrison GP, Lever AM (1992) The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 66: 4144–4153PubMedGoogle Scholar
  44. He F, Sun JD, Garrett ED, Cullen BR (1993) Functional organization of the bel-1 trans activator of human foamy virus. J Virol 67: 1896–1904PubMedGoogle Scholar
  45. Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201: 187–199PubMedGoogle Scholar
  46. Hooks JJ, Detrick-Hooks B (1981) Spumavirinae: foamy virus group infections: comparative aspects and diagnosis. In: Kurstak E, Kurstak C (eds) Comparative diagnosis of viral diseases, vol IV. Academic Press, New York, pp 599–618Google Scholar
  47. Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39: 169–185PubMedGoogle Scholar
  48. Hunter T, Karin M (1992) The regulation of transcription by phosphorylation. Cell 70: 375–387PubMedGoogle Scholar
  49. Jacks T (1990) Translational suppression in gene expression in retroviruses and retrotransposons. In: Swanstrom R, Vogt PK (eds) Retroviruses. Strategies of replication. Springer, Berlin Heidelberg New York, pp 93–124 (Current topics in microbiology and immunology, vol 157)Google Scholar
  50. Keller A, Partin KM, Löchelt M, Bannert H, Flügel RM, Cullen BR (1991) Characterization of the transcriptional trans-activator of human foamy virus. J Virol 65: 2589–2594PubMedGoogle Scholar
  51. Keller A, Garret ED, Cullen BR (1992) The bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J Virol 66: 3946–3949PubMedGoogle Scholar
  52. Kestler HW, Ringler DJ, Mori K, Panicalli DL, Sehgal PK, Daniel MD, Desrosiers R (1991) Importance of the nef gene for maintainance of high virus loads and for development of AIDS. Cell 65: 651–662PubMedGoogle Scholar
  53. Kim S, Ikeuchi K, Byrn R, Groopman J, Baltimore D (1989) Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86: 9544–9548PubMedGoogle Scholar
  54. Kirchhoff F, Voss G, Nick S, Stahl-Hennig C, Coulibaly C, Frank R, Jentsch K-D, Hunsmann G (1991) Antibody response to the regulatory factor (nef) in experimentally infected macaques: correlation with viremia, disease progression, and seroconversion to structural proteins. Virology 183: 267–272PubMedGoogle Scholar
  55. Kouzarides T, Ziff E (1988) The role of the leucine zipper in the fos-jun interaction. Nature 336: 646-651PubMedGoogle Scholar
  56. Kozak M (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 12: 857–872PubMedGoogle Scholar
  57. Kupiec J-J, Tobaly-Tapiero J, Canivet M, Santillana-Hayat M, Flügel RM, Peries J, Emanoil-Ravier R (1988) Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian foamy viruses. Nucleic Acids Res 16: 9557–9565PubMedGoogle Scholar
  58. Kupiec J-J, Kay A, Hayat M, Ravier R, Peries J, Galibert F (1991) Sequence analysis of the simian foamy virus type 1 genome. Gene 101: 185-194PubMedGoogle Scholar
  59. Lagaye S, Vexiau P, Morozov V, Guenebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Cathelineau G, Peries J, Emanoil-Ravier R (1992) Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves’ disease. Proc Natl Acad Sci USA 89: 10070–10074PubMedGoogle Scholar
  60. Landay AL, Jessop C, Lennette ET, Levy JA (1991) Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 338: 707–712PubMedGoogle Scholar
  61. Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Hunsmann G, Müler J, Müller-Hermelink H, Fuchs D, Wachter H, Daniel MM, Desrosiers RC, Fleckenstein B (1993) Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol 67: 902–912PubMedGoogle Scholar
  62. Latchman DS (1991) Eukaryotic transcription factors. Academic Press, London, pp 1–15Google Scholar
  63. Lee AH, Lee KJ, Kim S, Sung YC (1992) Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel-1 protein requires a specific DNA sequence. J Virol 66: 3236–3240PubMedGoogle Scholar
  64. Lee AH, Lee HY, Sung YC (1994) The gene expression of human foamy virus does not require a posttranscriptional transactivator. Virology 204: 409–413PubMedGoogle Scholar
  65. Lee KJ, Lee AH, Sung YC (1993) Multiple positive and negative cis-acting elements that mediate transactivation by bel-1 in the long terminal repeat of human foamy virus. J Virol 67: 2317–2326PubMedGoogle Scholar
  66. Lee CW, Chang J, Lee KJ, Sung YC (1994) The bel-1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids. J Virol 68: 2708–2719PubMedGoogle Scholar
  67. Linial ML, Miller AD (1990) Retroviral RNA packaging: sequence requirements and implications. In: Swanstrom R, Vogt PK (eds) Retroviruses-strategies of replication. Springer, Berlin Heidelberg New York, pp 125–152 (Current topics in microbiology and immunology, vol 157)Google Scholar
  68. Liu H, Bräutigam S, Rethwilm A (1993) Expression of the human foamy virus bel-1 transactivator in insect cells. Virus Res 30: 89–95Google Scholar
  69. Liu W-T, Natori T, Chang KSS, Wu AM (1977) Reverse transcriptase of foamy virus. Arch Virol 55: 187–200PubMedGoogle Scholar
  70. Löchelt M, Zentgraf H, Flügel RM (1991) Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of bel-1 gene. Virology 184: 43–54PubMedGoogle Scholar
  71. Löchelt M, Muranyi W, Flügel RM (1993a) Human foamy virus genome possesses an internal, bel-1-dependent and functional promoter. Proc Natl Acad Sci USA 90: 7317–7321PubMedGoogle Scholar
  72. Löchelt M, Aboud M, Flügel RM (1993b) Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res 21: 4226–4230PubMedGoogle Scholar
  73. Löchelt M, Flügel RM, Aboud M (1994) The human foamy virus internal promoter directs expression of the functional bel-1 transactivator and bet protein early after infection. J Virol 68: 638–645PubMedGoogle Scholar
  74. Loh PC (1993) Spumavirinae. In: Levy JA (ed) The Retroviridae, vol 2. Plenum Press, New York, pp 361–397Google Scholar
  75. Loh PC, Achong BC, Epstein MA (1977) Further biological properties of the human syncytial virus. Intervirology 8: 204–217PubMedGoogle Scholar
  76. Loh PC, Matsuura F, Mitzumoto C (1980) Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 13: 87–90PubMedGoogle Scholar
  77. Mahnke C, Kashaiya P, Rössler J, Bannert H, Levin A, Blattner WA, Dietrich M, Luande J, Löchelt M, Friedman-Kien AE, Komaroff AL, Loh PC, Westarp M-E, Flügel RM (1992) Human spumavirus antibodies in sera from African patients. Arch Virol 123: 243–253PubMedGoogle Scholar
  78. Maurer B, Flügel RM (1987) The 3′-orf protein of human immunodeficiency virus 2 shows sequence homology with the bel-3 gene of the human spumaretrovirus. FEBS Lett 222: 286–288PubMedGoogle Scholar
  79. Maurer B, Flügel RM (1988) Genomic organization of the human spumaretrovirus and its relatedness to AIDS and other retroviruses. AIDS Res Hum Retrovir 4: 467–473PubMedGoogle Scholar
  80. Maurer B, Bannert H, Darai G, Flügel RM (1988) Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol 62: 1590–1597PubMedGoogle Scholar
  81. Maurer B, Serfling E, ter Meulen V, Rethwilm A (1991) Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat. J Virol 65: 6353–6357PubMedGoogle Scholar
  82. McClure MO, Bieniasz PD, Schuz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA (1994) Isolation of a new foamy retrovirus from Orangutans. J Virol 68: 7124–7130PubMedGoogle Scholar
  83. Mergia A, Shaw KES, Lackner JE, Luciw PA (1990a) Relationship of the env genes and the endonuclease domain of the pol genes of simian foamy virus type 1 and human foamy virus. J Virol 64: 406–410PubMedGoogle Scholar
  84. Mergia A, Shaw KES, Pratt-Lowe E, Barry PE, Luciw PA (1990b) Simian foamy virus type 1 is a retrovirus which encodes a transcriptional transactivator. J Virol 64: 3598–3604PubMedGoogle Scholar
  85. Mergia A, Shaw KES, Pratt-Lowe E, Barry PE, Luciw PA (1991) Identification of the simian foamy virus transcriptional transactivator gene (taf). J Virol 65: 2903–2909PubMedGoogle Scholar
  86. Mergia A, Luciw PA (1991) Replication and regulation of primate foamy viruses. Virology 184: 475–482PubMedGoogle Scholar
  87. Mergia A, Pratt-Lowe E, Shaw KES, Renshaw-Gegg LW, Luciw PA (1992) Cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J Virol 66: 251–257PubMedGoogle Scholar
  88. Mergia A, Renshaw-Gegg LW, Stout MW, Renne R, Herchenröder O (1993) Functional domains of the simian foamy virus type 1 transcriptional transactivator (taf). J Virol 67: 4598–4604PubMedGoogle Scholar
  89. Mergia A (1994) Simian foamy virus type 1 contains a second promoter located at the 3′ end of the env gene. Virology 199: 219–222PubMedGoogle Scholar
  90. Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC (1990) NF-kB: a family of inducible and differentially expressed enhancer-binding proteins in human T-cells. Proc Natl Acad Sci USA 87: 10028–10032PubMedGoogle Scholar
  91. Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A (1980) The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J Gen Virol 47: 399–406PubMedGoogle Scholar
  92. Muranyi W, Flügel RM (1991) Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol 65: 727–735PubMedGoogle Scholar
  93. Nassal M (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107–4116PubMedGoogle Scholar
  94. Netzer K-O, Rethwilm A, Maurer B, ter Meulen V (1990) Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol 71: 1237–1241PubMedGoogle Scholar
  95. Netzer K-O, Schliephake, Maurer B, Watanabe R, Aguzzi A, Rethwilm A (1993) Identification of polrelated gene products of human foamy virus. Virology 192: 336–338PubMedGoogle Scholar
  96. Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172: 75–86PubMedGoogle Scholar
  97. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervirology 35: 196–207PubMedGoogle Scholar
  98. Pahl A, Flügel RM (1993) Endonucleolytic cleavages and DNA-joining activities of the integration protein of the human foamy virus. J Virol 67: 5426–5434PubMedGoogle Scholar
  99. Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689PubMedGoogle Scholar
  100. Regier JL, Shen F, Triezenberg SJ (1993) Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator. Proc Natl Acad Sci USA 90: 883–887PubMedGoogle Scholar
  101. Renne R, Friedl E, Scheizer M, Fleps U, Turek T, Neumann-Haefelin D (1992) Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology 186: 597–608PubMedGoogle Scholar
  102. Renne R, Mergia A, Renshaw-Gegg LW, Neumann-Haefelin D, Luciw PA (1993) Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3). Virology 192: 365–369PubMedGoogle Scholar
  103. Renshaw RW, Gonda MA, Casey JW (1991) Structure and transcriptional status of bovine syncytial virus in cytopathic infections. Gene 105: 179–184PubMedGoogle Scholar
  104. Renshaw RW, Casey JW (1994a) Transcriptional mapping of the 3′ end of the bovine syncytial virus genome. J Virol 68: 1021–1028PubMedGoogle Scholar
  105. Renshaw RW, Casey JW (1994b) Analysis of the 5′ long terminal repeat of bovine syncytial virus. Gene 141: 221–224PubMedGoogle Scholar
  106. Rethwilm A, Darai G, Rösen A, Maurer B, Flügel RM (1987) Molecular cloning of the genome of the human spumaretrovirus. Gene 59: 19–28PubMedGoogle Scholar
  107. Rethwilm A, Mori K, Maurer B, ter Meulen V (1990a) Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology 175: 568–571PubMedGoogle Scholar
  108. Rethwilm A, Baunach G, Netzer K-O, Maurer B, Borisch B, ter Meulen V (1990b) Infectious DNA of the human spumaretrovirus. Nucleic Acids Res 18: 733–738PubMedGoogle Scholar
  109. Rethwilm A, Erlwein O, Baunach G, Maurer B, ter Meulen V (1991) The transcriptional transactivator of human foamy virus maps to the bel-1 genomic region. Proc Natl Acad Sci USA 88: 941–945PubMedGoogle Scholar
  110. Saib A, Peries J, de The H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12: 4439–4444PubMedGoogle Scholar
  111. Schlicht H-J, Radziwill G, Schauer H (1989) Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins. Cell 56: 85–92PubMedGoogle Scholar
  112. Schliephake AW, Rethwilm A (1994) Nuclear localization of foamy virus gag precursor protein. J Virol 68: 4946–4954PubMedGoogle Scholar
  113. Schweizer M, Renne R, Neumann-Haefelin D (1989) Structural analysis of proviral DNA in simian foamy virus (LK-3)-infected cells. Arch Virol 109: 103–114PubMedGoogle Scholar
  114. Schweizer M, Fleps U, Jäckie A, Renne R, Turek R, Neumann-Haefelin D (1993) Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: reactivation by demethylation of proviral DNA. Virology 192: 663–666PubMedGoogle Scholar
  115. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D (1994). Absence of foamy virus DNA in Grave’s disease. AIDS Res Hum Retrovir 10: 601–605PubMedGoogle Scholar
  116. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer K-O, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995) Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FV prevalence in man. AIDS Res Hum Retrovir (in press)Google Scholar
  117. Stancek D, Stanekova-Gressnerova M, Janotka M, Hnilica P, Oravec D (1975) Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol 161: 133–144PubMedGoogle Scholar
  118. Svenningson A, Lycke J, Svennerholm B, Gronowitz S, Andersen O (1992) No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis. Annals Neurol 32: 711–714Google Scholar
  119. Teich N (1984) Taxonomy of retroviruses. In: Weiss RA, Teich N, Varmus HE, Coffin J (eds) RNA tumor viruses. Cold Spring Harbor Laboratory Press New York, pp 25–208Google Scholar
  120. Tobaly-Tapiero J, Kupiec J-J, Santillana-Hayat M, Canivet M, Peries J, Emanoil-Ravier R (1991) Further characterization of the gapped DNA intermediates of human spumavirus: evidence for dual initiation of plus-strand DNA synthesis. J Gen Virol 72: 605–608PubMedGoogle Scholar
  121. Venet A, Bourgault I, Aubertin A-M, Kieny M-P, Levy J-P (1992) Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. J Immunol 148: 2899–2908PubMedGoogle Scholar
  122. Venkatesh LK, Chinnadurai G (1993) The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. J Virol 67: 3868–3876PubMedGoogle Scholar
  123. Venkatesh LK, Theodorakis PA, Chinnadurai G (1991) Distinct cis-acting regions in U3 regulate transactivation of the human spumaretrovirus long terminal repeat by the viral bel-1 gene product. Nucleic Acids Res 19: 3661–3666PubMedGoogle Scholar
  124. Venkatesh LK, Yang C, Theodorakis PA, Chinnadurai G (1993) Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol 67: 161–169PubMedGoogle Scholar
  125. Weiss RA (1988) A virus in search for a disease. Nature 333: 497–498PubMedGoogle Scholar
  126. Weissenberger J, Flügel RM (1994) Identification and characterization of the bel 3 protein foamy virus. AIDS Res Hum Retrovir 10: 595–600PubMedGoogle Scholar
  127. Werner J, Gelderblom H (1979) Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet I: 258–259Google Scholar
  128. Westarp M-E, Komhuber HH, Rössler J, Flügel RM (1992) Human spuma retrovirus antibodies in amyotrophic lateral sclerosis. Neurol Psychiatry Brain Res 1:1–4Google Scholar
  129. Wick G, Grubeck-Loebenstein B, Trieb K, Kalischnig G, Aguzzi A (1992) Human foamy virus antigens in thyroid tissue of Graves’ disease patients. Int Arch Allergy Immunol 99: 153`–156PubMedGoogle Scholar
  130. Wick G, Trieb K, Aguzzi A, Recheis H, Anderl H, Grubeck-Loebenstein B (1993) Possible role of human foamy virus in Graves’ disease. Intervirology 35: 101–107PubMedGoogle Scholar
  131. Young D, Samuels J, Clarke JK (1973) A foamy virus of possible human origin isolated in BHK-21 cells. Arch Ges Virusforsch 42: 228–234PubMedGoogle Scholar
  132. Yu SF, Linial ML (1993) Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol 67: 6618–6624PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • A. Rethwilm
    • 1
  1. 1.Institute of Virology and ImmunobiologyUniversity of WürzburgWürzburgGermany

Personalised recommendations